earnings
confidence high
sentiment positive
materiality 0.80
Bristol Myers Q1 revenue $11.3B, GAAP EPS $1.07, Non-GAAP $2.05; affirms non-GAAP guidance
BRISTOL MYERS SQUIBB CO
2023-Q1 EPS reported
$1.07
revenue$11,337,000,000
- Q1 2023 revenues $11.3B, down 3% YoY; in-line & new product portfolio grew 8% (10% ex-FX).
- GAAP diluted EPS $1.07 (up 81% YoY); Non-GAAP EPS $2.05 (up 5% YoY).
- Net impact from acquired IPRD charges and licensing income was ($0.01) per share on both GAAP and non-GAAP.
- Company adjusts GAAP 2023 EPS guidance; affirms non-GAAP financial guidance for 2023.
- CEO Giovanni Caforio cites strong commercial execution and milestone achievements in pipeline.